Improved quality of life for malignant ascites patients by Denver peritoneovenous shunts

Anticancer Research

Volumn 26, Issue 3 B, 2006, Pages 2393-2395

  Tomiyama, Koji ^a,b,c,d   Takahashi, Mina ^b   Fujii, Tetsuya ^b   Kunisue, Hironori ^b   Kanaya, Yoshiaki ^b   Maruyama, Shuitirou ^b   Yokoyama, Nobuji ^b   Nakao, Atsunori ^c   Soda, Mitsuhiro ^b   Shimizu, Nobuyoshi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d E1505 Biomedical Science Tower ^*  (United States)

Author keywords

Denver shunt; Malignant ascites; Peritoneal dissemination

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; ASCITES TUMOR; BODY WEIGHT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HEMATOMA; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; LUNG EDEMA; MALE; OCCLUSION; PERITONEUM VEIN SHUNT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; SHUNTING;

ADULT; AGED; AGED, 80 AND OVER; ASCITES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PERITONEOVENOUS SHUNT; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 33745582505     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Leveen HH, Christoudias G, Ip M et al: Peritoneovenous shunting for ascites. Ann Surg 180: 580-591, 1974.
2. Weaver DW, Wiencek RG, Bouwman DL et al: Percutaneous Denver peritoneovenous shunt insertion. Am J Surg 759: 600-601, 1990.
3. Matsuda T: Prevention and early diagnosis of disseminated intravascular coagulation. Nippon Naika Gakkai Zasshi 82: 1375-1382, 1993.
4. Harmon DC, Demirjian Z, Ellman L et al: Disseminated intravascular coagulation with the peritoneovenous shunt. Ann Intern Med 90: 774-746, 1979.
5. LeVeen HH, Wapnick S, Grosberg S et al: Further experience with peritoneovenous shunt for ascites. Ann Surg 184: 574-581, 1976.
6. Tawes RL, Sydorak GR, Kennedy PA et al: Coagulopathy associated with peritoneovenous shunting. Am J Surg 142: 51-55, 1981.
7. Agarwal S, Joyner KA Jr and Swaim MW: Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Am J Gastroenterol 95: 3218-3224, 2000.
8. Gleysteen JJ, Hussey CV and Heckman MG: The cause of coagulopathy after peritoneovenous shunt for malignant ascites. Arch Surg 125: 474-477, 1990.
9. Lerner RG, Nelson JC, Corines P et al: Disseminated intravascular coagulation. Complication of LeVeen peritoneovenous shunts. JAMA 240: 2064-2066, 1978.
10. Maat B, Oosterlee J, Spaas JA et al: Dissemination of tumour cells via LeVeen shunt. Lancet 1: 988, 1979.
11. Downing R, Black J and Windsor CW: Palliation of malignant ascites by the Denver peritoneovenous shunt. Ann R Coll Surg Engl 66: 340-343, 1984.